Rich Pharmaceuticals, Inc.
company.status.inactiveCIK 1504389fmd_0ST9XP31BGQB6T61DRZ6TE7W77Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2010 to Mar 31, 2018, 29 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | – | – | 0 |
| Cost of revenue | – | 0 | 0 | 0 | 0 | 0 | – |
| Gross profit | – | 0 | (0) | (0) | – | – | – |
| Research and development | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 0 | 0 | 3 | 4 | 1 | 1 | 1 |
| Compensation and benefits | – | 0 | 0 | 1 | 0 | 0 | 1 |
| Operating income | (0) | (0) | (3) | (4) | (0) | (1) | (1) |
| Interest expense | – | 0 | (0) | (0) | (0) | (0) | (1) |
| Other non-operating income (expense) | – | – | – | – | – | (2) | (0) |
| Net income from continuing operations | (0) | (0) | – | – | – | – | – |
| Net income | (0) | (0) | (3) | (4) | (2) | (3) | (2) |